My colleague Don recently wrote a blog
post about the importance of doing reporting and analysis throughout the
course of a patient recruitment campaign for a clinical trial. As a data
analyst, I could not agree more!
One of my first enrollment campaign analyses illustrated the
importance of analyzing enrollment data. As part of this final analysis of a
recruitment campaign for a clinical trial involving patients with multiple
sclerosis, we compared advertising costs per referral in different-sized
markets.
Historically, when it comes to broadcast media advertising,
we have seen the best return on investment in mid-sized markets. This makes
intuitive sense: The effort (i.e., cost)
needed to turn up patients with a rare condition in a city of 100,000 can be
enormous. Planning a media buy in large markets, such as the New York metropolitan
area, in order to recruit for a study site on Long Island can be equally
expensive.
For this particular multiple sclerosis trial, a first look
at media advertising costs showed a fairly linear “dose-response” relationship
between market size and costs per referral:
However, when digital advertising referrals and costs were added
in to the analysis, the relationship between cost per referral and DMA
population weakened considerably:
Cost per referral - Offline advertising only |
Cost per referral - Both online and offline advertising |
This indicated that digital advertising tactics were very cost-effective for the enrollment campaign, regardless of the target markets’ population size.
Looking exclusively at cost per online referral by population size confirmed that digital advertising yielded a fairly consistent cost per referral regardless of market size:
This small analysis confirmed that digital advertising can
be a smart advertising choice for very large markets, not only for multiple
sclerosis, but also for a variety of other therapeutic conditions. All the more reason why incorporating data analysis into your
decision-making process leads to more cost-effective enrollment campaigns!
No comments:
Post a Comment